Alaris plans $6 million cost cuts by 2002:
This article was originally published in Clinica
Executive Summary
Alaris Medical, a US intravenous infusion therapy system manufacturer, will save $6 million annually by 2002 following restructuring of manufacturing, affecting two factories in the US and one in the UK. Manual assembly operations, notably from its plant in Creedmoor, North Carolina, will be moved to Tijuana, Mexico. The company will take a $6.5 million charge across the third and fourth quarters, with the cuts offering a $1.5 million net saving this year, $5 million next and $6 million thereafter. Sales from the San Diego, California company slipped from $93 million to $91 million in the first quarter, while net losses rose from $725,000 to $5 million compared to the same period in 1999.
You may also be interested in...
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.